Tandem Diabetes Care has announced the commercial launch of the Tandem Mobi insulin delivery system in the US.
Tandem Mobi is said to be the world’s smallest, automated insulin delivery system for individuals with diabetes.
Go deeper with GlobalData
Tandem has started accepting orders for the system and is shipping the product to eligible customers across the country.
Tandem Mobi represents a new approach to managing diabetes, leveraging the company’s Control-IQ technology.
This Control-IQ hybrid closed-loop system is approved for use by individuals aged six and above with type 1 diabetes.
In several clinical trials and real-world studies, the system was shown to improve time in range both day and night.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe Tandem Mobi system is less than half the size of the insulin pump, t:slim X2.
Users can wear the device on-body using a lightweight adhesive sleeve, clip it to their clothing, or simply slip it into a pocket.
The system is compatible with all existing Tandem-branded infusion sets produced by Convatec, including a new 5in tubing option specifically for Tandem Mobi.
These infusion sets provide users with the ability to disconnect temporarily for convenience and offer over 30 combinations of infusion site and tubing lengths.
The Tandem Mobi mobile app has full iOS control via a compatible iPhone.
In terms of sensor compatibility, it works with the DexCom G6 Continuous Glucose Monitoring (CGM) System, with plans to integrate with Dexcom G7 in the second quarter of 2024 and the Abbott FreeStyle Libre 3 sensor thereafter.
Said to be water-resistant, the Tandem Mobi features flexible pump control with a physical button for insulin bolus delivery without the need for an iPhone. It also incorporates advanced technology such as wireless charging and the capability for remote software updates.
Tandem Diabetes Care president and CEO John Sheridan said: “This tiny, wearable pump exceeded the expectations of users from an early access program, and we are thrilled to begin offering this exciting new technology to more people in the diabetes community.
“With this launch, we are executing our strategy to offer a differentiated portfolio of durable insulin pumps, providing choice, along with new options in wearability.”
Last year, Tandem launched the latest version of the t:slim X2 insulin pump software, which is integrated with the DexCom G7 CGM system, in the US.
